SHIFTBIO INC.

Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure

Nature Communications
Impact Factor: 14.7
Feb 2025

view detail

Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure
Nature Communications
Impact Factor: 14.7
Feb 2025

view detail

Controlled delivery of HIF-1α via extracellular vesicles with collagen-binding activity for enhanced wound healing

Journal of Controlled Release
Impact Factor: 10.5
Apr 2025

view detail

Controlled delivery of HIF-1α via extracellular vesicles with collagen-binding activity for enhanced wound healing
Journal of Controlled Release
Impact Factor: 10.5
Apr 2025

view detail

Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity

Advanced Science
Impact Factor: 14.3
April 2024

view detail

Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity
Advanced Science
Impact Factor: 14.3
April 2024

view detail

Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.

Small
Impact Factor: 13.7
May 2023

view detail

Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy.
Small
Impact Factor: 13.7
May 2023

view detail

Small Extracellular Vesicles as a New Class of Medicines

Pharmaceutics
Impact Factor: 4.9
Jan 2023

view detail

Small Extracellular Vesicles as a New Class of Medicines
Pharmaceutics
Impact Factor: 4.9
Jan 2023

view detail

Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.

Journal of Controlled Release
Impact Factor: 10.5
Nov 2022

view detail

Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.
Journal of Controlled Release
Impact Factor: 10.5
Nov 2022

view detail

Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy

Advanced Materials
Impact Factor: 30.2
Dec 2020

view detail

Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
Advanced Materials
Impact Factor: 30.2
Dec 2020

view detail

Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity

Science Advances
Impact Factor: 11.7
Jul 2020

view detail

Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity
Science Advances
Impact Factor: 11.7
Jul 2020

view detail

Functionalized exosome harboring bioactive molecules for cancer therapy

Cancer Letters
Impact Factor: 9.1
Oct 2020

view detail

Functionalized exosome harboring bioactive molecules for cancer therapy
Cancer Letters
Impact Factor: 9.1
Oct 2020

view detail

Intrinsic cancer vaccination

Advanced Drug Delivery Reviews
Impact Factor: 15.2
Nov 2019

view detail

Intrinsic cancer vaccination
Advanced Drug Delivery Reviews
Impact Factor: 15.2
Nov 2019

view detail

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery

Journal of Extracellular Vesicles
Impact Factor: 15.5
Dec 2018

view detail

Extracellular vesicles as a platform for membrane-associated therapeutic protein delivery
Journal of Extracellular Vesicles
Impact Factor: 15.5
Dec 2018

view detail

Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer

Advanced Materials
Impact Factor: 30.2
Mar 2018

view detail

Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
Advanced Materials
Impact Factor: 30.2
Mar 2018

view detail

Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis

Biomaterials
Impact Factor: 12.8
Mar 2017

view detail

Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis
Biomaterials
Impact Factor: 12.8
Mar 2017

view detail

Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes

Advanced Materials
Impact Factor: 30.2
Mar 2017

view detail

Virus‐mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes
Advanced Materials
Impact Factor: 30.2
Mar 2017

view detail

Publication